Profile

Craig D. Gordon, MD

Founder, Chief Executive Officer, and Chief Investment Officer

GordonMD® Global Investments LP

In addition to being a licensed rheumatologist, Dr. Gordon is an investment manager, who has personally managed on average $7 billion or more, and provided help in overseeing additional portfolios totaling billions more.

BACKGROUND

Prior to establishing GordonMD® Global Investments in 2021, Dr. Gordon worked at The Capital Group for 10+ years as an Equity Investment Analyst investing in and covering U.S. and Japanese biotechnology and pharmaceutical companies. In this capacity, he conducted research and built his own differentiated portfolio, taking into consideration numerous factors including but not limited to appropriate sizing, risk levels, and timing of milestones.

Dr. Gordon worked for the Cowen Group in New York as a Biotechnology Equity Research Analyst and Associate before joining Capital Group in 2010.

01

Accomplishments

  • Managed multiple fund mandates including U.S. Growth, Global Growth, and Small / Private Investments for over a decade, leading to strong annualized absolute and relative returns plus 3-year rolling returns.
  • Rated among the best Investment Analysts within Capital Research Global Investors for a decade.
  • Co-head of the Healthcare Cluster at Capital Research Global Investors.
  • Established Capital Group’s first-ever drug pricing network.
  • Extensive experience in participating in private biotechnology placements.
02

Medical Experience

  • Emergency Room Physician and Internal Medicine Hospitalist in four North Carolina hospitals.
  • Rheumatology Fellow at Duke Medical Center.
  • Medical Resident Teaching Award from Jackson Memorial Hospital.
03

Education

  • Duke University - Fuqua School of Business: MBA.
  • University of Miami, Miller School of Medicine: Doctor of Medicine (with research distinction).
  • Cornell University: B.A.- Economics (with distinction).
04

Board Memberships

  • R&D and Innovation Board of Children’s Hospital Los Angeles (CHLA).
  • Board of Antios Therapeutics, Inc.
  • Board of SalioGen Therapeutics, Inc.
  • Board of Spotlight Therapeutics, Inc.
  • Board of Soley Therapeutics, Inc.
  • Board of Gennao Bio, Inc.